{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:28:19Z","timestamp":1788388099887,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the timing of enucleation, treatment course, and outcome for retinoblastoma (RB) with optic nerve (ON) invasion on imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Retrospective clinical study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Of the 160 patients with RB who presented to the National Center for Child Health and Development in Japan between 2005 and 2022, ON invasion on imaging at the initial presentation was seen in five patients. The clinical, computed tomography (CT), and magnetic resonance imaging (MRI) findings, and treatment courses were reviewed retrospectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MRI showed ON invasion in all five patients (three with unilateral RB, 2 with bilateral RB); in two patients CT detected no invasion. Enucleation was performed in four patients, three of whom underwent neoadjuvant therapy and one had a positive ON resection margin following the enucleation as initial treatment. One patient did not undergo enucleation due to cerebrospinal fluid dissemination. All enucleated patients underwent adjuvant chemotherapy. Four patients underwent radiotherapy. During follow-up (mean, 89.4 months), four patients survived and one died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MRI is recommended to evaluate ON invasion and determine the timing of enucleation for RB. The appropriate choice of neoadjuvant or adjuvant therapy would be helpful to avoid radiotherapy for RB with ON invasion on imaging.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10384-024-01112-z","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T07:02:05Z","timestamp":1727506925000},"page":"741-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of five cases of retinoblastoma with optic nerve invasion on imaging"],"prefix":"10.1007","volume":"68","author":[{"given":"Tamae","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shion","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazuki","family":"Morikawa-Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Kiyotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Terashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"1112_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","volume":"379","author":"H Dimaras","year":"2012","unstructured":"Dimaras H, Kinami K, Dimba EA, Gronsdhal P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436\u201346.","journal-title":"Retinoblastoma Lancet"},{"key":"1112_CR2","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1016\/S2214-109X(22)00250-9","volume":"10","author":"The Global Retinoblastoma Study Group","year":"2022","unstructured":"The Global Retinoblastoma Study Group. The global retinoblastoma outcome study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022;10:e1128\u201340.","journal-title":"Lancet Glob Health"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.3390\/cancers13092216","volume":"13","author":"AB Daniels","year":"2021","unstructured":"Daniels AB, Patel SN, Milam RW, Kohanim S, Friedman DL, Koyama T. Effect of intravenous chemotherapy regimen on globe salvage success rates for retinoblastoma based on disease class-a meta-analysis. Cancers (Basel). 2021;13:2216.","journal-title":"Cancers (Basel)"},{"key":"1112_CR4","doi-asserted-by":"publisher","first-page":"101002","DOI":"10.1002\/pbc.26270","volume":"64","author":"JL Berry","year":"2017","unstructured":"Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Linn Murhee A, et al. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017;64:101002.","journal-title":"Pediatr Blood Cancer"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/pbc.21735","volume":"52","author":"GL Chantada","year":"2009","unstructured":"Chantada GL, Guitter MR, Fandi\u00f1o AC, Raslawski EC, DeDavila MTG, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of optic nerve. Pediatr Blood Cancer. 2009;52:218\u201322.","journal-title":"Pediatr Blood Cancer"},{"key":"1112_CR6","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.ophtha.2012.01.029","volume":"119","author":"V Radhakrishanan","year":"2012","unstructured":"Radhakrishanan V, Kashyap S, Pschker N, Sharma S, Pathy S, Mohanti BK, et al. Outcome, pathologic finings, and compliance in orbital retinoblastoma (international retinoblastoma staging system stage III) treated with neoadjuvant chemotherapy: a prospective study. Ophthalmology. 2012;119:1470\u20137.","journal-title":"Ophthalmology"},{"key":"1112_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/bjophthalmol-2014-306222","volume":"99","author":"A K\u00fcnkele","year":"2015","unstructured":"K\u00fcnkele A, Wilm J, Holdt M, Lohman D, Bornfeld N, Eggert A, et al. Neoadjuvant\/adjuvant treatment of high-risk retinoblastoma: a report from the German retinoblastoma referral centre. Br J Ophthalmol. 2015;99:949\u201353.","journal-title":"Br J Ophthalmol"},{"key":"1112_CR8","doi-asserted-by":"publisher","first-page":"e27998","DOI":"10.1002\/pbc.27998","volume":"67","author":"ML Choucair","year":"2020","unstructured":"Choucair ML, Brisse HJ, Freneaux P, Desjardins L, Dorfm\u00fcller G, Puget S, et al. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion. Pediatr Blood Cancer. 2020;67:e27998.","journal-title":"Pediatr Blood Cancer"},{"key":"1112_CR9","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.3390\/cancers13246240","volume":"13","author":"J Zhao","year":"2021","unstructured":"Zhao J, Feng Z, Leung G, Gallie BL. Retinoblastoma survival following primary enucleation by AJCC staging. Cancers (Basel). 2021;13:6240.","journal-title":"Cancers (Basel)"},{"key":"1112_CR10","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","volume":"113","author":"CL Shields","year":"2006","unstructured":"Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276\u201380.","journal-title":"Ophthalmology"},{"key":"1112_CR11","doi-asserted-by":"publisher","first-page":"e28572","DOI":"10.1002\/pbc.28572","volume":"67","author":"K Okada","year":"2020","unstructured":"Okada K, Soejima T, Sakamoto H, Hirato J, Hara J. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: a report from the Japanese pediatric brain tumor consortium. Pediatr Blood Cancer. 2020;67:e28572.","journal-title":"Pediatr Blood Cancer"},{"key":"1112_CR12","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","volume":"24","author":"RJ Packer","year":"2006","unstructured":"Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202\u20138.","journal-title":"J Clin Oncol"},{"key":"1112_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00381-006-0282-5","volume":"23","author":"S Okada","year":"2007","unstructured":"Okada S, Hongo T, Sakaguchi K, Suzuki K, Nishizawa S, Ohzeki T. Pilot study of ifosfamide\/carboplatin\/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. Childs Nerv Syst. 2007;23:407\u201313.","journal-title":"Childs Nerv Syst"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/bjo.87.3.327","volume":"87","author":"E Bellaton","year":"2003","unstructured":"Bellaton E, Bertozzi A, Behar C, Suzuki K, Nishizawa S, Ohzeki T. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol. 2003;87:327\u20139.","journal-title":"Br J Ophthalmol"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/13816810.2018.1502790","volume":"39","author":"B Chawla","year":"2018","unstructured":"Chawla B, Chaurasia S, Sharma S, Pattebahadur R, Hasan F, Seth R, et al. Magnetic resonance imaging for tumor restaging after chemotherapy in retinoblastoma with optic nerve invasion. Ophthalmic Genet. 2018;39:584\u20138.","journal-title":"Ophthalmic Genet"},{"key":"1112_CR16","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.4103\/ijo.IJO_1611_18","volume":"67","author":"U Kim","year":"2019","unstructured":"Kim U, Rathi G, Chowdhary G, Srinavasan KG, Shanthi R, Prabhu Krishna RS. Accuracy of preoperative imaging in predicting optic nerve invasion in retinoblastoma: a retrospective study. Indian J Ophthalmol. 2019;67:2019\u201322.","journal-title":"Indian J Ophthalmol"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000531354","volume":"9","author":"M Chiranthan","year":"2023","unstructured":"Chiranthan M, Meel R, Sharma S, Lomi N, Kashyap S, Bajaj MS. Can enhancement pattern in normal-sized optic nerves on magnetic resonance imaging better predict tumor invasion in retinoblastoma eyes? Ocul Oncol Pathol. 2023;9:107\u201314.","journal-title":"Ocul Oncol Pathol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01112-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:05:05Z","timestamp":1732867505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01112-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01112-z","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Onishi, None; S. Nishina, None; T. Yokoi, None; T. Yoshida, None; S. Hayashi, None; H. Anzai, None; N. Azuma, None; C. Kiyotani, None; K. Terashima, None; T. Yoshioka, None; H. Ogiwara, None; H. Fuji, None; M. Kitamura, None; Y. Tsutsumi, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}